Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 019938/0234 | |
| Pages: | 4 |
| | Recorded: | 10/10/2007 | | |
| Attorney Dkt #: | SER-LS-MISC |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/06/2001
|
Application #:
|
08983576
|
Filing Dt:
|
04/15/1998
|
|
Title:
|
METHODS FOR DETECTING, IDENTIFYING, ISOLATING, AND SELECTIVELY LABELLING AND TARGETING TH1 LYMPHOCYTE BY MEANS OF THE LAG-3 PROTEIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/19/2002
|
Application #:
|
09319014
|
Filing Dt:
|
01/06/2000
|
|
Title:
|
MUTANTS OF THE LAG-3 PROTEINS, PRODUCTS FOR THE EXPRESSION OF THESE MUTANTS AND USE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/31/2002
|
Application #:
|
09319147
|
Filing Dt:
|
12/01/1999
|
|
Publication #:
|
|
Pub Dt:
|
06/27/2002
| | | | |
|
Title:
|
METHODS FOR PREVENTING GRAFT REJECTION IN TRANSPLANTATION AND FOR PRODUCING A UNIVERSAL GENE THERAPY HOST CELL USING LYMPHOCYTE ACTIVATION (LAG-3)
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/25/2002
|
Application #:
|
09492113
|
Filing Dt:
|
01/27/2000
|
|
Title:
|
USE OF MHC CLASS II LIGANDS AS ADJUVANT FOR VACCINATION AND OF LAG-3 IN CANCER TREATMENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/19/2006
|
Application #:
|
10041600
|
Filing Dt:
|
01/10/2002
|
|
Publication #:
|
|
Pub Dt:
|
12/19/2002
| | | | |
|
Title:
|
USE OF MHC CLASS II LIGANDS AS ADJUVANT FOR VACCINATION AND OF LAG-3 IN CANCER TREATMENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/16/2000
|
Application #:
|
29096531
|
Filing Dt:
|
11/13/1998
|
|
Title:
|
SYRINGE HOLDER
|
|
|
Assignee
|
|
|
|
|
| CENTRE INDUSTRIEL |
| COINSINS, VAUD, SWITZERLAND 1267 |
|
|
Correspondence name and address
|
| |
FRANK C. EISENSCHENK, PH.D.
|
| |
P.O. BOX 142950
|
| |
GAINESVILLE, FL 32614-2950
|
Search Results as of:
05/24/2024 02:33 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
